Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Filed with BSE · ISIN INE194R01017 · · 10 pages · English
Fredun Pharmaceuticals Ltd. on 6ix
Earlier from Fredun Pharmaceuticals
- Announcement under Regulation 30 (LODR)-Press Release / Media Release
- Announcement under Regulation 30 (LODR)-Allotment
- Revised Outcome Of Board Meeting Dated 03Rd October, 2026.
- Board Meeting Outcome for Allotment Of 1,82,400 Equity Shares To Non-Promoter Allottees Pursuant To Conversion Of 60,800 Warrants Into Equity Shares, Consequent To The 1: 2 Bonus Issue.
- Fredun Pharmaceuticals Ltd. Press Release Sep 22 2026
Later from Fredun Pharmaceuticals
- Board Meeting Outcome for Outcome Of The Board Meeting
- Financial Results For The Quarter Ended 30Th September, 2026.
- Approved The Proposal For Making An Application To National Stock Exchange Of India Limited (NSE) For Listing And Trading Of The Equity Shares Of The Company On NSE.
- Announcement under Regulation 30 (LODR)-Newspaper Publication
- Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Follow Fredun Pharmaceuticals into a list and get an email when it puts out news.
Follow Fredun Pharmaceuticals